June 23, 2026 · Form 4 insider transaction
Fordyce Marshall sold 88 shares of Vera Therapeutics, Inc. at $38.43 per share, a transaction worth $3.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.